Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision
Authors not listed
Zhongshan Ophthalmic Center, Sun Yat-sen University · 2023
Abstract
Glaucoma, age-related macular degeneration (AMD), retinitis pigmentosa, RP, diabetic retinopathy (DR) are the most common blinding eye diseases in the world. Vision and visual field are often severely impaired, quality of life is reduced, and personal and family burdens are heavy. This kind of low vision people, can use visual AIDS and other instruments for visual rehabilitation training, maximize the function of residual vision, improve the quality of life. Beyes, HOLA, Acesight and OXSIGHT are among the latest eyeglasses devices that are expected to improve the quality of life for people with low vision. This research group intends to recruit advanced patients with primary glaucoma, AMD, RP, DR and other common blinding eye diseases who visited Zhongshan Ophthalmology Center of Sun Yat-sen University from June 2021 to December 2022 to study the changes of visual function and quality of life after wearing this new type of head-worn visual aids, and analyze relevant factors combined with clinical data. To evaluate the effect and influencing factors of the new head-mounted visual AIDS on patients, and provide theoretical basis for subsequent clinical research.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2023). Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision. <em>Zhongshan Ophthalmic Center, Sun Yat-sen University</em>. https://clinicaltrials.gov/study/NCT06076720
Vancouver
Anonymous. Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision. Zhongshan Ophthalmic Center, Sun Yat-sen University. 2023.
BibTeX
@misc{anon2023Evalua,
title = {Evaluation of New Head-mounted Visual Aids Among Patients With Low Vision},
author = {Anonymous},
journal = {Zhongshan Ophthalmic Center, Sun Yat-sen University},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Dr. med. Katja Hatz 2017
Open access · US-GOV
Correlation Between Reading Specific New Visual Acuity Measurement Methods, Patient Self-reported Quality of Life Assessments, Macular Morphological Parameters and Standardized Study Protocol ETDRS Visual Acuity in Wet AMD Patients
China National Center for Cardiovascular Diseases 2025
Open access · US-GOV
Evaluation of Surgical Techniques and Outcomes Across the Lifespan in Congenital Heart Disease Based on a Chinese Multicenter Database
Genentech, Inc. 2023
Open access · US-GOV
A Phase IIa, Multicenter, Open-label, Single-Arm Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Archives of Ophthalmology 2002
Citation only
Self-management of Age-Related Macular Degeneration and Quality of Life
University of Iowa 2003
Open access · US-GOV
Clinical Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate Sterile Suspension
Retinow Health Technologies and R&D Industry Joint Stock Company 2023
Open access · US-GOV